Ernexa Therapeutics Inc. Preferred Stock, Liquidation Preference, Value
Ernexa Therapeutics Inc. (ERNA) had Preferred Stock, Liquidation Preference, Value of $156.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockLiquidationPreferenceValue · last filed 2026-08-06
- 2026-06-30: Preferred Stock, Liquidation Preference, Value $156.00K.
- 2026-03-31: Preferred Stock, Liquidation Preference, Value $156.00K.
- 2025-12-31: Preferred Stock, Liquidation Preference, Value $156.00K.
- 2025-09-30: Preferred Stock, Liquidation Preference, Value $156.00K.
| Period end | Preferred Stock, Liquidation Preference, Value |
|---|---|
| 2026-06-30 | $156.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $156.00K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $156.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $156.00K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $156.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $156.00K 10-Q · filed 2025-05-07 |
| 2024-12-31 | $156.00K 10-K · filed 2026-03-13 |
| 2024-09-30 | $156.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $156.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $156.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $156.00K 10-K · filed 2025-03-12 |
| 2023-09-30 | $156.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $156.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $156.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $156.00K 10-K · filed 2024-03-14 |
| 2022-09-30 | $156.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $156.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $156.00K 10-Q · filed 2022-07-01 |
| 2021-12-31 | $156.00K 10-K · filed 2023-03-20 |
| 2020-12-31 | $156.00K 10-K/A · filed 2022-07-01 |
| 2020-09-30 | $156.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $156.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $156.00K 10-Q · filed 2020-05-20 |
| 2019-12-31 | $156.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $156.00K 10-Q · filed 2019-11-01 |
| 2019-06-30 | $156.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $156.00K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $156.00K 10-K · filed 2020-03-19 |
| 2018-09-30 | $156.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $156.00K 10-Q · filed 2018-08-06 |
| 2018-03-31 | $156.00K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $156.00K 10-K · filed 2019-03-22 |
| 2016-12-31 | $156.00K 10-K · filed 2018-03-09 |
| 2014-12-31 | $156.00K 10-K · filed 2015-03-27 |
| 2013-12-31 | $156.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |